AETHLON MEDICAL, INC.
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $2.5M | $2.7M | $2.3M | $2.1M | $927.0K | $896.0K | $586.0K | $673.0K |
| SG&A Expense | $3.9M | $4.5M | $3.5M | $2.5M | $1.5M | $953.5K | $792.6K | $849.5K |
| Operating Income | $-12.6M | $-11.9M | $-10.4M | $-7.9M | $-5.9M | $-6.0M | $-4.8M | $-6.1M |
| Operating Margin | — | -2,072.0% | -3,542.5% | -1,197.3% | -912.0% | -2,612.5% | -3,228.8% | -1,555.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-12.2M | $-12.0M | $-10.4M | $-7.9M | $-6.4M | $-6.2M | $-5.7M | $-7.3M |
| Net Margin | — | -2,094.9% | -3,540.9% | -1,196.6% | -980.3% | -2,697.8% | -3,795.9% | -1,855.8% |
| EPS (Basic) | $-9.72 | $-1.47 | $-0.18 | $-0.16 | $-0.47 | $-1.28 | $-0.03 | $-0.24 |
| EPS (Diluted) | $-9.72 | $-1.47 | $-0.18 | $-0.16 | $-0.47 | $-1.28 | $-0.03 | $-0.24 |
| Shares Outstanding (Basic) | 1.3M | 8.2M | 59.0M | 61.5M | 48.2M | 76.4M | 71.0M | 35.5M |
| Shares Outstanding (Diluted) | 1.3M | 8.2M | 59.0M | 61.5M | 48.2M | 76.4M | 71.0M | 35.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |